Digillect LLC

Revel Pharmaceuticals Inc, based in San Francisco, is at the forefront of developing innovative therapeutic solutions aimed at reversing the underlying drivers of aging and chronic diseases. The company's approach focuses on repairing damage caused by autoimmunity and clearing toxic metabolites that contribute to various health issues. With a diverse team of experienced scientists and advisors, Revel Pharmaceuticals is dedicated to pioneering therapies that target the root causes of aging, striving to improve health outcomes and enhance quality of life. Their commitment to addressing age-related damage positions them as a leader in the biopharmaceutical industry. Generated from the website

Cairn Biosciences is a San Francisco-based biotech company that specializes in discovering new medicines by mapping multiscale cell dynamics. Their proprietary COMPASS discovery platform utilizes innovative simulations of living biology to navigate complex disease biology and unlock exclusive routes to novel targets and drugs, with a focus on overcoming acquired resistance to targeted cancer therapies. With a diverse and multidisciplinary team of experts in drug discovery, disease biology, engineering, and computation, Cairn Biosciences is pioneering a new drug discovery paradigm. Their team, led by established biopharma leader and serial drug discovery innovator Mary Ludlam, is dedicated to delivering better therapeutics through their expertise in synthetic cell biology, high-throughput microscopy, computational analysis, and more.Generated from the website

ProLynx, LLC is a biotechnology company based in San Francisco, California, focused on advancing innovative solutions in the field. The company prides itself on a strong management team and a dedicated board of directors, leveraging their expertise to drive research and development initiatives. With a commitment to technological advancement, ProLynx develops products aimed at enhancing the efficiency of therapeutic pipelines. The organization is also engaged in ongoing research efforts, showcasing its dedication to fostering advancements in biotechnology. Generated from the website